Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-03-05Clinical Trial Update: Postoperative Use of Zoledronic Acid in Breast Cancer Patients After Neoadjuvant Chemotherapy [Phase 3]
A Phase 3 clinical trial evaluating postoperative zoledronic acid in breast cancer patients after neoadjuvant chemotherapy has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-04Clinical Trial Update: Six vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast Cancer [Phase 3]
A Phase 3 trial comparing six months versus twelve months of trastuzumab with docetaxel after FEC as adjuvant therapy for node-positive brea…
-
CLINICAL_TRIALS withdrawal · 2015-03-04Clinical Trial Update: Histologic Diagnoses of Incidentally Detected Lesions on MRI
The study NCT00579735, sponsored by the University of Arkansas and focused on histologic diagnoses of incidentally detected MRI lesions in b…
-
CLINICAL_TRIALS withdrawal · 2015-03-04Clinical Trial Update: Hydralazine as Demethylating Agent in Breast Cancer [Phase 1, Phase 2]
A Phase 1/Phase 2 trial evaluating hydralazine as a demethylating agent in breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-03-04Clinical Trial Update: Use of Breast MRI for Local Staging
The clinical trial evaluating breast MRI for local staging in breast cancer has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-03-03Clinical Trial Update: A Study of Avastin (Bevacizumab) + Xeloda (Capecitabine)as Maintenance Therapy in Patients With HER2-Negative Metastatic Breast Cancer [Phase 3]
A Phase 3 trial evaluating Avastin (bevacizumab) plus capecitabine as maintenance therapy for HER2-negative metastatic breast cancer has com…
-
CLINICAL_TRIALS withdrawal · 2015-02-27Clinical Trial Update: Role of Surgery for the Primary in Patients With Breast Cancer Stage IV. [Phase 3]
A Phase 3 trial evaluating the role of removing the primary breast tumor in patients with stage IV breast cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-02-26Clinical Trial Update: Hand in Hand. Psychological Support and Counseling to Breast Cancer Patients and Their Partners [NA]
A completed clinical trial evaluating psychological support and counseling for breast cancer patients and their partners.
-
CLINICAL_TRIALS trial_result · 2015-02-25Clinical Trial Update: Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases [Phase 2]
Phase 2 trial update of afatinib alone or in combination with vinorelbine in HER2-positive breast cancer with brain metastases; results were…
-
CLINICAL_TRIALS trial_result · 2015-02-24Clinical Trial Update: Broccoli Sprout Extract in Treating Women Who Have Had a Mammogram and Breast Biopsy [Phase 2]
A Phase 2 clinical trial tested broccoli sprout extract in women who had a mammogram and breast biopsy to treat breast cancer and precancero…
-
CLINICAL_TRIALS trial_result · 2015-02-24Clinical Trial Update: The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer [Phase 3]
Phase 3 trial evaluates efficacy and tolerability of combining Faslodex (fulvestrant) and Aromasin (exemestane) in hormone receptor-positive…
-
CLINICAL_TRIALS trial_result · 2015-02-23Clinical Trial Update: Phase II Study of Capecitabine and Cisplatin to Treat Metastatic Triple Negative Breast Cancer [Phase 2]
Phase II results update for a capecitabine and cisplatin regimen in metastatic triple-negative breast cancer. The results were posted in 201…
-
CLINICAL_TRIALS trial_result · 2015-02-23Clinical Trial Update: Melatonin Versus Placebo in Breast Cancer [EARLY_Phase 1]
An early Phase 1 trial compared melatonin to placebo in breast cancer patients to assess safety and early efficacy signals. Results were pos…
-
CLINICAL_TRIALS trial_result · 2015-02-20Clinical Trial Update: Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer [Phase 2]
Phase 2 trial evaluating goserelin with letrozole or anastrozole in premenopausal women with stage II-III estrogen receptor-positive breast …
-
CLINICAL_TRIALS trial_result · 2015-02-19Clinical Trial Update: Study of CR011-vcMMAE to Treat Locally Advanced or Metastatic Breast Cancer [Phase 1, Phase 2]
This update reports that a phase 1/2 trial of CR011-vcMMAE for locally advanced or metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast Cancer [Phase 2]
Phase II trial of Abraxane, Avastin (bevacizumab), and carboplatin in triple-negative metastatic breast cancer completed; results were poste…
-
CLINICAL_TRIALS trial_result · 2015-02-16Clinical Trial Update: Study of Physiological and High Dose Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating physiological and high-dose estradiol for hormone receptor-positive metastatic breast cancer has complet…
-
CLINICAL_TRIALS research · 2015-02-16Clinical Trial Update: Life Quality and Mental State in Patients With Breast Cancer [Phase 4]
A completed Phase 4 clinical trial update assessing quality of life and mental state in patients with breast cancer.
-
FDA approval · 2015-02-13FDA Approved: LETROZOLE — Supplemental Application (Accord Healthcare, Inc.)
FDA approved a supplemental application for Accord Healthcare's generic letrozole, confirming regulatory authorization for this product. Thi…
-
FDA approval · 2015-02-13FDA Approved: LETROZOLE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for letrozole, a generic aromatase inhibitor used to treat breast cancer in postmenopausal wome…
-
CLINICAL_TRIALS trial_result · 2015-02-13Clinical Trial Update: Metabolic Changes as a Diagnostic Indicator for Cancer
The Hasselt University clinical trial evaluating metabolic changes as a diagnostic indicator for cancer has completed, studying breast cance…
-
CLINICAL_TRIALS trial_result · 2015-02-12Clinical Trial Update: Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ [Phase 3]
Phase 3 trial evaluated whether mometasone furoate can prevent radiation dermatitis in patients undergoing radiation therapy for breast canc…
-
CLINICAL_TRIALS trial_result · 2015-02-10Clinical Trial Update: Predicting Response to Capecitabine in Women With Metastatic Breast Cancer [NA]
A completed clinical trial update examining biomarkers to predict response to capecitabine in women with metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2015-02-10Clinical Trial Update: Trastuzumab in Treating Women With Metastatic Breast Cancer [NA]
The clinical trial of trastuzumab in women with metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-02-10Clinical Trial Update: Sentinel Node Biopsy Following NeoAdjuvant Chemotherapy in Biopsy Proven Node Positive Breast Cancer [NA]
This is a completed clinical trial entry evaluating sentinel lymph node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive…